Novavax (NVAX) Stock Price
$6.67 0%
to add to portfolio
AI Score
-
Alternative
4 -
Fundamental
2 -
Technical
4
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Novavax, AI stock picks, stock alerts and much more.
NVAX AI Stock Analysis
AI stock analysis for NVAX is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Novavax (NVAX) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Novavax (NVAX) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Novavax (NVAX), currently trading at $6.67, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About NVAX
-
Novavax, Inc.
-
Symbol
NVAX
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
1.1B
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$23.45 1.1% |
5 |
 |
Inovio Pharmaceuticals INO |
$1.87 2.6% |
2 |
 |
Moderna MRNA |
$27.22 0.6% |
3 |
 |
Anavex Life Sciences AVXL |
$9.42 0.3% |
5 |
 |
BridgeBio Pharma BBIO |
$36.31 1% |
4 |
News
NVAX Alternative Data
Web Traffic
Novavax receives an estimated 48100 monthly visitors to novavax.com.
-
Web Traffic
48100
-
Change from Previous Month
44.8%
-
3 Month Change
6.1%
-
YoY Change
6.1%
Twitter Followers
Novavax has 60,864 Twitter Followers on its main Twitter (also known as X) account.
-
Twitter Followers
60864
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0.6%
-
YoY Change
0.6%
Facebook Engagement
Novavax has engaged 9 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
9
-
Daily Change
0%
-
1 Month Change
50%
-
3 Month Change
0%
-
YoY Change
0%
Youtube Subscribers
Novavax has 1,140 subscribers on its main Youtube channel.
-
Youtube Subscribers
1140
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
LinkedIn Followers
72,996 are following Novavax on LinkedIn, up by 0.5% over the last month.
-
LinkedIn Followers
72996
-
Daily Change
0%
-
1 Month Change
0.5%
-
3 Month Change
1.3%
Job Postings
Novavax has an estimated 0 open job postings, which is down -100% over the last month.
-
Job Postings
0
-
Daily Change
100%
-
1 Month Change
100%
-
3 Month Change
100%
-
YoY Change
100%
LinkedIn Employees
According to LinkedIn, Novavax has 1,142 employees, down by -3.1% over the last month.
-
LinkedIn Employees
1142
-
Daily Change
3.1%
-
1 Month Change
3.1%
-
3 Month Change
3.8%
-
YoY Change
3.8%
News Mentions
Novavax was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
100%
-
1 Month Change
100%
-
3 Month Change
100%
Reddit Mentions
Novavax has been mentioned an estimated 1 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
1
-
Daily Change
0%
-
1 Month Change
0%
Business Outlook
According to employee reviews, the business outlook among employees at Novavax is 19 out of 100 (very bearish).
-
Business Outlook
19
-
Change from Previous Month
9.5%
-
3 Month Change
0%
-
YoY Change
0%
NVAX Financials
NVAX Key Metrics
-
Total Revenue
$88.3M
-
Net Income
-$81M
-
Earnings per Share
-$0.51
-
Free cash flow
-$175.4M
-
EBITDA
-$53.5M
-
EBITDA Ratio
-0.605576
-
Total Assets
$1.6B
NVAX 2-year Revenue & Income
NVAX 2-year Free Cash Flow
NVAX Technicals
NVAX SMA
NVAX RSI
FAQ
What's the current price of Novavax (NVAX) Stock?
The price of an Novavax (NVAX) share is $6.67.
What's the market cap of Novavax?
The current market cap of Novavax is 1.1B.
Should I buy or sell NVAX?
Novavax shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Novavax is better viewed as a hold or accumulate position while waiting for further developments.
Is Novavax a good investment?
The current analysis of Novavax's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Novavax's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Novavax (NVAX) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Novavax stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Novavax (NVAX) that investors often compare it to?
Novavax (NVAX) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Novavax's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Novavax's stock price to be around $6.29 in 2026. Starting from the current price of $6.67, this represents a 5.6% change in price, indicating a bearish outlook for the stock.
How to buy Novavax (NVAX) Stock?
Novavax stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Novavax shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.